Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01085903 · ClinicalTrials.gov registry record · Phase 2
Identifying and Treating Arousal Related Deficits in Neglect and Dysphagia
A Phase 2 study, sponsored by University of Arkansas.
- Completed
- Registry status
- Phase 2
- Development phase
- 28
- Enrollment target
NCT01085903 is a Phase 2 study that has completed, run by University of Arkansas. The registered enrollment target is 28 participants.
The verdict
NCT01085903, a Phase 2 study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to examine how stroke can alter arousal, alertness, neglect and dysphagia, and whether a medication, modafinil, can improve arousal.
Interventions
- DRUG Placebo
- DRUG Modafinil
- BEHAVIORAL Baseline
- BEHAVIORAL CPS
- BEHAVIORAL Post CPS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2010-03 |
| Est. Completion | 2015-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01085903
The ClinicalTrials.gov registry entry for NCT01085903 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT01085903 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01085903 about?
NCT01085903 is a clinical study titled "Identifying and Treating Arousal Related Deficits in Neglect and Dysphagia". The purpose of this study is to examine how stroke can alter arousal, alertness, neglect and dysphagia, and whether a medication, modafinil, can improve arousal.
What is the current status of trial NCT01085903?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 28 participants. The study started on 2010-03. Estimated completion is 2015-08.
What interventions are being tested in trial NCT01085903?
The interventions under investigation include: Placebo (DRUG), Modafinil (DRUG), Baseline (BEHAVIORAL), CPS (BEHAVIORAL), Post CPS (BEHAVIORAL).
Who is sponsoring clinical trial NCT01085903?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.